Hyaluronic Acid Viscosupplement Modulates Inflammatory Mediators in Chondrocyte and Macrophage Coculture via MAPK and NF-κB Signaling Pathways
ACS Omega · 14.05.2024 · 9 (19) · 21467-21483
DOI: 10.1021/acsomega.4c01911 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Omega, online erschienen am 01.05.2024. Verfasst von Sree Samanvitha Kuppa und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, Chonnam National University Medical School, Hwasun 58128, Korea. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Korea Medical Device Development Fund.
Abstract (Originalsprache)
Osteoarthritis (OA) is a chronic musculoskeletal disorder characterized by cartilage degeneration and synovial inflammation. Paracrine interactions between chondrocytes and macrophages play an essential role in the onset and progression of OA. In this study, in replicating the inflammatory response during OA pathogenesis, chondrocytes were treated with interleukin-1β (IL-1β), and macrophages were treated with lipopolysaccharide and interferon-γ. In addition, a coculture system was developed to simulate the biological situation in the joint. In this study, we examined the impact of hyaluronic acid (HA) viscosupplement, particularly Hyruan Plus, on chondrocytes and macrophages. Notably, this viscosupplement has demonstrated promising outcomes in reducing inflammation; however, the underlying mechanism of action remains elusive. The viscosupplement attenuated inflammation, showing an inhibitory effect on nitric oxide production, downregulating proinflammatory cytokines such as matrix metalloproteinases (MMP13 and MMP3), and upregulating the expression levels of type II collagen and aggrecan in chondrocytes. HA also reduced the expression level of inflammatory cytokines such as IL-1β, TNF-α, and IL-6 in macrophages, and HA exerted an overall protective effect by partially suppressing the MAPK pathway in chondrocytes and p65/NF-κB signaling in macrophages. Therefore, HA shows potential as a viscosupplement for treating arthritic joints.
Autor:innen und Institutionen
- Department of Biomedical Sciences, Chonnam National University Medical School, Hwasun 58128, Korea.
- Department of Orthopaedics Surgery, Center for Joint Disease of Chonnam National University Hwasun Hospital, 322 Seoyang-ro, Hwasun-eup, Jeonnam 519-763, Korea.
- Korea Biomedical Materials and Devices Innovation Research Center of Chonnam National University Hospital, 42, Jebong-ro, Dong-gu, Gwangju 501-757, Korea.
ORCID-Profile: Jong Keun Seon
Förderung
- Korea Medical Device Development Fund
Zitieren
APA
Kuppa, S. S., Kang, J. Y., Yang, H. Y., Lee, S. C., Sankaranarayanan, J., Kim, H. K., & Seon, J. K. (2024). Hyaluronic Acid Viscosupplement Modulates Inflammatory Mediators in Chondrocyte and Macrophage Coculture via MAPK and NF-κB Signaling Pathways. ACS Omega, 9(19), 21467-21483. https://doi.org/10.1021/acsomega.4c01911
Vancouver
Kuppa SS, Kang JY, Yang HY, Lee SC, Sankaranarayanan J, Kim HK, et al. Hyaluronic Acid Viscosupplement Modulates Inflammatory Mediators in Chondrocyte and Macrophage Coculture via MAPK and NF-κB Signaling Pathways. ACS Omega. 2024;9(19):21467-21483. doi:10.1021/acsomega.4c01911
BibTeX
@article{Kuppa2024,
author = {Kuppa, Sree Samanvitha and Kang, Ju Yeon and Yang, Hong Yeol and Lee, Seok Cheol and Sankaranarayanan, Jaishree and Kim, Hyung Keun and Seon, Jong Keun},
title = {Hyaluronic Acid Viscosupplement Modulates Inflammatory Mediators in Chondrocyte and Macrophage Coculture via MAPK and NF-κB Signaling Pathways},
journal = {ACS Omega},
year = {2024},
volume = {9},
number = {19},
pages = {21467--21483},
doi = {10.1021/acsomega.4c01911}
}
EUVIMED